Citations in impact factor journals
An Overview on Arsenic Trioxide-Induced
Cardiotoxicity Cardiovascular Toxicology |
Chemotherapeutic doses of arsenic trioxide delays hepatic regeneration by oxidative stress and hepatocyte apoptosis in partial hepatectomy rat Toxicology and Applied Pharmacology |
Citation to this article as recorded by
Arsenic trioxide, a cancer chemo drug hampers fibrotic liver
regeneration by interrupting oxidative stress rekindling and stellate cell
rejuvenation Journal of Cellular Physiology |
Multicenter evaluation of arsenic trioxide dosing in obese patients with low–intermediate risk acute promyelocytic leukemia Leukemia & Lymphoma Vol. 60, Issue 14, 3557, 2019 |
Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemia Journal of Oncology Pharmacy Practice |
How to cite this article
R. Hosseini, A. Mandegary, K. Alimoghaddam, A. Ghavamzadeh and M.H. Ghahremani, 2008. Pharmacokinetic of Arsenic Trioxide in Newly Diagnosed Acute Promyelocytic
Leukemia Patients. Journal of Applied Sciences, 8: 4617-4623.
DOI: 10.3923/jas.2008.4617.4623
URL: https://scialert.net/abstract/?doi=jas.2008.4617.4623
DOI: 10.3923/jas.2008.4617.4623
URL: https://scialert.net/abstract/?doi=jas.2008.4617.4623